Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes (INTENSE3MIX)

Novo Nordisk

Status: Completed

Conditions: Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin

Study type: Observational

Funder types: Industry

Identifiers

NCT00712478

BIASP-1866

Details and patient eligibility

About

This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.

Enrollment: 114 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetes patients
• Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
• HbA1c greater than or equal to 8.0%

Exclusion criteria

• Patients not performing glycaemia self-measurements
• Secondary diabetes
• Requirement of or use of an insulin pump
• Treatment with corticoids

Trial design

114 participants in 1 patient group

A

Treatment:

Drug: insulin